SomaLogic, Inc.
NASDAQ: SLGC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Stephen A. Williams BS, MB,
- Employees
- 451
- Headquarters
- Boulder, United States
- IPO year
- 2021
- Market cap
- $396.2M
- Website
- https://www.somalogic.com
Loading SLGC…
Loading profile data…Frequently asked questions about SLGC
What does SomaLogic, Inc. (SLGC) do?
SomaLogic, Inc. is a U.S.-based enterprise specializing in the identification of protein biomarkers and the development of clinical diagnostic solutions. A core aspect of its technology involves the creation of slow off-rate modified aptamers (SOMAmers) – unique nucleic acid-based reagents meticulously designed to specifically bind with their ta...
Where does SLGC trade?
SomaLogic, Inc. (SLGC) trades on the NASDAQ Global Market.
What sector is SLGC in?
SomaLogic, Inc. (SLGC) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of SomaLogic, Inc.?
Stephen A. Williams BS, MB, is the chief executive officer of SomaLogic, Inc. (SLGC).
Where is SomaLogic, Inc. headquartered?
SomaLogic, Inc. is headquartered in United States.
Does SLGC pay a dividend?
SomaLogic, Inc. (SLGC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SLGC go public?
SomaLogic, Inc. (SLGC) completed its initial public offering in 2021.